Erd, Hungary

Enikö Molnar


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Enikö Molnar - Innovator in Pharmaceutical Intermediates

Introduction

Enikö Molnar, a notable inventor based in Erd, Hungary, has made significant contributions to the field of pharmaceuticals. With a keen focus on the preparation of optically active carbamates, his innovative work plays a vital role in developing essential pharmaceutical intermediates.

Latest Patents

Enikö holds a patent for "Optically Active Carbamates, Process for Preparation Thereof and Use Thereof as Pharmaceutical Intermediates." This patent details the compound 1-[(4-chlorophenyl)-phenylmethyl]-4-(2,2,2-trichloroethoxycarbonyl)-piperazine, alongside its optically isomers. The invention is crucial for the synthesis of 1-(4-chlorophenyl)-phenylmethyl-piperazine and its optical isomers and salts, which serve as vital intermediates in creating non-sedating antihistamine-type active pharmaceutical ingredients.

Career Highlights

Enikö is affiliated with Egis Gyógyszergyár Nyilvánosan Muködö Részvénytársaság, a prominent pharmaceutical company committed to drug research and development. His work reflects a commitment to enhancing pharmaceutical intermediates, showcasing his expertise and skill in the field.

Collaborations

Throughout his career, Enikö has collaborated with colleagues such as Tibor Mezei and Péter Trinka. These collaborations highlight the importance of teamwork and collective effort in the innovative process, leading to advancements in pharmaceutical development.

Conclusion

Enikö Molnar is a distinguished inventor whose contributions to the pharmaceutical industry have had a lasting impact. His patent work not only showcases his innovation but also emphasizes the critical role of pharmaceutical intermediates in drug development. With ongoing collaboration and research, Enikö continues to be a valuable asset in the realm of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…